Sphera Funds Management
Latest statistics and disclosures from Sphera Funds Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are TEVA, XBI, SNY, NICE, CYTK, and represent 24.35% of Sphera Funds Management's stock portfolio.
- Added to shares of these 10 stocks: TEVA (+$18M), JSPR (+$15M), CATX (+$15M), BBIO (+$11M), PRAX (+$11M), CYBN (+$11M), S (+$7.9M), Outlook Therapeutics (+$6.8M), AMAT (+$6.6M), CAMT (+$6.3M).
- Started 25 new stock positions in NTR, CAMT, ESTC, CPRX, VRNS, Alto Neuroscience, QCOM, CYBN, GERN, AAPL.
- Reduced shares in these 10 stocks: NVMI (-$17M), ATXS (-$15M), RNAC (-$14M), FUSN (-$14M), TSEM (-$12M), XBI (-$11M), INBX (-$8.6M), ALPN (-$7.5M), Praxis Precision Medicines I (-$7.3M), AMD (-$7.1M).
- Sold out of its positions in APGE, ARWR, COGT, Freeline Therapeutics Holdings, GILD, Gracell Biotechnologies, INBX, Jasper Therapeutics, MDGL, GLUE. MORF, ORIC, PTCT, PANW, Praxis Precision Medicines I, REPL, RIGL, PRTA, MDWD.
- Sphera Funds Management was a net seller of stock by $-7.6M.
- Sphera Funds Management has $712M in assets under management (AUM), dropping by 14.55%.
- Central Index Key (CIK): 0001496201
Tip: Access up to 7 years of quarterly data
Positions held by Sphera Funds Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Sphera Funds Management
Sphera Funds Management holds 97 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 10.0 | $71M | +33% | 5.0M | 14.11 |
|
| Spdr Ser Tr S&p Biotech Put Option (XBI) | 5.1 | $36M | -24% | 380k | 94.89 |
|
| Sanofi Sponsored Adr (SNY) | 3.4 | $24M | 500k | 48.60 |
|
|
| Nice Sponsored Adr (NICE) | 3.1 | $22M | +26% | 86k | 260.62 |
|
| Cytokinetics Com New (CYTK) | 2.8 | $20M | +8% | 282k | 70.11 |
|
| Bridgebio Pharma (BBIO) | 2.8 | $20M | +125% | 636k | 30.92 |
|
| Syndax Pharmaceuticals (SNDX) | 2.7 | $19M | +5% | 813k | 23.80 |
|
| Biogen Idec (BIIB) | 2.1 | $15M | +52% | 71k | 215.63 |
|
| Jasper Therapeutics Com New (JSPR) | 2.1 | $15M | NEW | 505k | 29.36 |
|
| IsoRay (CATX) | 2.1 | $15M | +48373% | 12M | 1.19 |
|
| Ultragenyx Pharmaceutical (RARE) | 1.9 | $14M | +46% | 294k | 46.69 |
|
| Merck & Co (MRK) | 1.9 | $14M | -16% | 104k | 131.95 |
|
| Kura Oncology (KURA) | 1.8 | $13M | -13% | 611k | 21.33 |
|
| Astrazeneca Sponsored Adr (AZN) | 1.8 | $13M | +5% | 190k | 67.75 |
|
| Sentinelone Cl A (S) | 1.8 | $13M | +158% | 551k | 23.31 |
|
| Johnson & Johnson (JNJ) | 1.8 | $13M | 80k | 158.19 |
|
|
| Meta Platforms Cl A (META) | 1.7 | $12M | -25% | 25k | 485.58 |
|
| Celldex Therapeutics Com New (CLDX) | 1.6 | $12M | -35% | 277k | 41.97 |
|
| Microsoft Corporation (MSFT) | 1.6 | $12M | +15% | 28k | 420.72 |
|
| Eli Lilly & Co. (LLY) | 1.6 | $11M | 14k | 777.96 |
|
|
| Praxis Precision Medicines I Com New (PRAX) | 1.5 | $11M | NEW | 177k | 61.02 |
|
| Novo-nordisk A S Adr (NVO) | 1.5 | $11M | -10% | 83k | 128.40 |
|
| Cybin Ord (CYBN) | 1.5 | $11M | NEW | 26M | 0.41 |
|
| Inozyme Pharma (INZY) | 1.5 | $11M | -12% | 1.4M | 7.66 |
|
| Jfrog Ord Shs (FROG) | 1.4 | $9.9M | +104% | 224k | 44.22 |
|
| Amazon (AMZN) | 1.4 | $9.8M | -2% | 54k | 180.38 |
|
| Fusion Pharmaceuticals (FUSN) | 1.3 | $9.6M | -58% | 449k | 21.32 |
|
| Pharvaris N V (PHVS) | 1.3 | $9.1M | +60% | 393k | 23.11 |
|
| Mineralys Therapeutics (MLYS) | 1.2 | $8.5M | -11% | 659k | 12.91 |
|
| Day One Biopharmaceuticals I (DAWN) | 1.1 | $8.1M | -3% | 493k | 16.52 |
|
| Global E Online SHS (GLBE) | 1.1 | $7.6M | -22% | 209k | 36.35 |
|
| Wix SHS (WIX) | 1.0 | $7.3M | -8% | 53k | 137.48 |
|
| Sarepta Therapeutics (SRPT) | 1.0 | $7.2M | +42% | 56k | 129.46 |
|
| Immatics SHS (IMTX) | 1.0 | $7.0M | +7% | 666k | 10.51 |
|
| Abbvie (ABBV) | 1.0 | $6.9M | -17% | 38k | 182.10 |
|
| Outlook Therapeutics | 1.0 | $6.8M | NEW | 571k | 11.94 |
|
| Merus N V (MRUS) | 0.9 | $6.7M | -35% | 149k | 45.03 |
|
| Applied Materials (AMAT) | 0.9 | $6.6M | NEW | 32k | 206.23 |
|
| Camtek Ord (CAMT) | 0.9 | $6.3M | NEW | 75k | 83.77 |
|
| NOVA MEASURING Instruments L (NVMI) | 0.9 | $6.2M | -73% | 35k | 177.38 |
|
| Tower Semiconductor Shs New (TSEM) | 0.8 | $6.0M | -66% | 180k | 33.45 |
|
| 89bio (ETNB) | 0.8 | $6.0M | +26% | 516k | 11.64 |
|
| Vigil Neuroscience (VIGL) | 0.8 | $5.9M | +223% | 1.7M | 3.41 |
|
| 4068594 Enphase Energy (ENPH) | 0.8 | $5.7M | -29% | 47k | 120.98 |
|
| Ventyx Biosciences (VTYX) | 0.8 | $5.5M | +451% | 993k | 5.50 |
|
| Taboola.com Ord Shs (TBLA) | 0.7 | $5.3M | -30% | 1.2M | 4.44 |
|
| 4d Molecular Therapeutics In (FDMT) | 0.7 | $5.2M | NEW | 162k | 31.86 |
|
| Incyte Corporation (INCY) | 0.7 | $5.1M | 90k | 56.97 |
|
|
| Rocket Pharmaceuticals (RCKT) | 0.7 | $4.9M | -3% | 184k | 26.94 |
|
| Novartis Sponsored Adr (NVS) | 0.7 | $4.8M | -16% | 50k | 96.73 |
|
| Solaredge Technologies (SEDG) | 0.7 | $4.8M | -10% | 67k | 70.98 |
|
| Disc Medicine (IRON) | 0.6 | $4.6M | NEW | 74k | 62.26 |
|
| Catalyst Pharmaceutical Partners (CPRX) | 0.6 | $4.6M | NEW | 288k | 15.94 |
|
| GSK Sponsored Adr (GSK) | 0.6 | $4.3M | 100k | 42.87 |
|
|
| Vistagen Therapeutics Ord (VTGN) | 0.6 | $4.3M | 809k | 5.28 |
|
|
| Applied Therapeutics (APLT) | 0.6 | $4.2M | NEW | 619k | 6.80 |
|
| ACADIA Pharmaceuticals (ACAD) | 0.6 | $4.2M | NEW | 225k | 18.49 |
|
| Werewolf Therapeutics (HOWL) | 0.6 | $4.1M | 627k | 6.48 |
|
|
| Akero Therapeutics (AKRO) | 0.6 | $4.1M | NEW | 160k | 25.26 |
|
| Shl Telemedicine Sponsored Ads (SHLT) | 0.5 | $3.9M | 633k | 6.10 |
|
|
| Pliant Therapeutics (PLRX) | 0.5 | $3.9M | +33% | 259k | 14.90 |
|
| Promis Neurosciences Com New (PMN) | 0.5 | $3.5M | 1.8M | 1.91 |
|
|
| Springworks Therapeutics (SWTX) | 0.5 | $3.5M | -58% | 70k | 49.22 |
|
| Alector (ALEC) | 0.5 | $3.4M | NEW | 560k | 6.02 |
|
| Apple (AAPL) | 0.4 | $3.0M | NEW | 18k | 171.48 |
|
| Alnylam Pharmaceuticals Call Option (ALNY) | 0.4 | $3.0M | -64% | 20k | 149.45 |
|
| Enlight Renewable Energy SHS (ENLT) | 0.4 | $2.9M | 169k | 16.92 |
|
|
| Rezolute Com New (RZLT) | 0.4 | $2.5M | 997k | 2.55 |
|
|
| Qualcomm (QCOM) | 0.4 | $2.5M | NEW | 15k | 169.30 |
|
| Pfizer (PFE) | 0.4 | $2.5M | 90k | 27.75 |
|
|
| Elevation Oncology (ELEV) | 0.3 | $2.2M | -52% | 430k | 5.13 |
|
| Elastic N V Ord Shs (ESTC) | 0.3 | $2.0M | NEW | 20k | 100.24 |
|
| Advanced Micro Devices (AMD) | 0.3 | $2.0M | -78% | 11k | 180.49 |
|
| Compugen Ord (CGEN) | 0.3 | $2.0M | 769k | 2.58 |
|
|
| Nutrien (NTR) | 0.3 | $1.9M | NEW | 36k | 54.31 |
|
| Kezar Life Sciences (KZR) | 0.3 | $1.8M | 2.1M | 0.90 |
|
|
| Aprea Therapeutics Com New (APRE) | 0.3 | $1.8M | NEW | 270k | 6.69 |
|
| Alpine Immune Sciences (ALPN) | 0.2 | $1.8M | -80% | 45k | 39.64 |
|
| Five9 (FIVN) | 0.2 | $1.7M | +83% | 28k | 62.11 |
|
| Cargo Therapeutics (CRGX) | 0.2 | $1.7M | 75k | 22.32 |
|
|
| Astria Therapeutics (ATXS) | 0.2 | $1.6M | -90% | 113k | 14.07 |
|
| Amylyx Pharmaceuticals (AMLX) | 0.2 | $1.4M | +78% | 507k | 2.84 |
|
| Prime Medicine (PRME) | 0.2 | $1.4M | +177% | 205k | 7.00 |
|
| Upwork (UPWK) | 0.2 | $1.4M | -53% | 117k | 12.26 |
|
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 0.2 | $1.4M | NEW | 35k | 39.24 |
|
| Broadcom (AVGO) | 0.2 | $1.3M | -44% | 1.0k | 1325.41 |
|
| Geron Corporation (GERN) | 0.2 | $1.3M | NEW | 384k | 3.30 |
|
| Lava Therapeutics Nv SHS (LVTX) | 0.2 | $1.2M | NEW | 368k | 3.33 |
|
| Gossamer Bio (GOSS) | 0.2 | $1.2M | -23% | 1.0M | 1.18 |
|
| Varonis Sys (VRNS) | 0.1 | $943k | NEW | 20k | 47.17 |
|
| Insmed Com Par $.01 Call Option (INSM) | 0.1 | $762k | NEW | 28k | 27.13 |
|
| Icl Group SHS (ICL) | 0.1 | $702k | -68% | 131k | 5.38 |
|
| Selecta Biosciences (RNAC) | 0.1 | $489k | -96% | 25k | 19.50 |
|
| Alto Neuroscience Com Shs | 0.1 | $468k | NEW | 31k | 15.35 |
|
| Immatics *w Exp 07/01/202 (IMTXW) | 0.0 | $270k | 100k | 2.70 |
|
|
| Arbe Robotics Ordinary Shares (ARBE) | 0.0 | $90k | 43k | 2.09 |
|
|
| Annexon Put Option (ANNX) | 0.0 | $82k | NEW | 11k | 7.17 |
|
Past Filings by Sphera Funds Management
SEC 13F filings are viewable for Sphera Funds Management going back to 2013
- Sphera Funds Management 2024 Q1 filed May 15, 2024
- Sphera Funds Management 2023 Q4 restated filed Feb. 15, 2024
- Sphera Funds Management 2023 Q4 filed Feb. 14, 2024
- Sphera Funds Management 2023 Q3 filed Nov. 14, 2023
- Sphera Funds Management 2023 Q2 filed Aug. 14, 2023
- Sphera Funds Management 2023 Q1 filed May 15, 2023
- Sphera Funds Management 2022 Q4 filed Feb. 14, 2023
- Sphera Funds Management 2022 Q3 filed Nov. 14, 2022
- Sphera Funds Management 2022 Q2 filed Aug. 15, 2022
- Sphera Funds Management 2022 Q1 filed May 16, 2022
- Sphera Funds Management 2021 Q4 filed Feb. 14, 2022
- Sphera Funds Management 2021 Q3 filed Nov. 15, 2021
- Sphera Funds Management 2021 Q2 filed Aug. 17, 2021
- Sphera Funds Management 2021 Q1 filed May 17, 2021
- Sphera Funds Management 2020 Q4 filed Feb. 16, 2021
- Sphera Funds Management 2020 Q3 filed Nov. 12, 2020